JO
PLRX icon

John Overdeck’s Pliant Therapeutics PLRX Stock Holding History

John Overdeck’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
2,262,832
+9,694
+0.4% +$11.8K ﹤0.01% 2775
2026
Q1 		$2.84M Buy
2,253,138
+1,299,845
+136% +$1.64M ﹤0.01% 2479
2025
Q4 		$1.16M Buy
953,293
+170,038
+22% +$255K ﹤0.01% 2816
2025
Q3 		$1.16M Buy
783,255
+505,097
+182% +$771K ﹤0.01% 2480
2025
Q2 		$323K Buy
278,158
+2,871
+1% +$4.06K ﹤0.01% 2763
2025
Q1 		$372K Buy
275,287
+178,209
+184% +$1.08M ﹤0.01% 2634
2024
Q4 		$1.28M Sell
97,078
-38,044
-28% -$519K ﹤0.01% 2018
2024
Q3 		$1.51M Sell
135,122
-110,450
-45% -$1.38M ﹤0.01% 1849
2024
Q2 		$2.64M Buy
245,572
+138,548
+129% +$1.79M 0.01% 1366
2024
Q1 		$1.59M Buy
+107,024
New +$1.77M ﹤0.01% 1643
2023
Q4 		– Sell
-102,709
Closed -$1.78M – 3324
2023
Q3 		$1.78M Sell
102,709
-216,577
-68% -$3.75M ﹤0.01% 1485
2023
Q2 		$5.79M Sell
319,286
-97,364
-23% -$2.3M 0.01% 859
2023
Q1 		$11.1M Buy
416,650
+199,205
+92% +$5.67M 0.03% 554
2022
Q4 		$4.2M Sell
217,445
-30,562
-12% -$639K 0.01% 937
2022
Q3 		$5.18M Buy
248,007
+234,007
+1,671% +$4.48M 0.02% 736
2022
Q2 		$112K Sell
14,000
-111,278
-89% -$712K ﹤0.01% 2256
2022
Q1 		$878K Buy
125,278
+9,309
+8% +$95K ﹤0.01% 1766
2021
Q4 		$1.57M Buy
+115,969
New +$1.84M ﹤0.01% 2144

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

John Overdeck's PLRX Position: Q2 2026 in Review

John Overdeck increased its Pliant Therapeutics (PLRX) stake by 0.43% in Q2 2026, buying an estimated $11.8K and bringing the position to 2,262,832 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2775.

John Overdeck first reported a position in PLRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $11.1M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • John Overdeck held 2,262,832 shares of Pliant Therapeutics worth $2.58M as of Q2 2026.
  • John Overdeck bought 9,694 Pliant Therapeutics shares in Q2 2026, an estimated $11.8K.
  • Pliant Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2775 holding.
  • John Overdeck first reported a position in Pliant Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • John Overdeck's Pliant Therapeutics position peaked at $11.1M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.